| 000 | 01489 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250511201140.0 | ||
| 264 | 0 | _c19901024 | |
| 008 | 199010s 0 0 eng d | ||
| 022 | _a0735-7907 | ||
| 024 | 7 |
_a10.3109/07357909009017558 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBajorin, D | |
| 245 | 0 | 0 |
_aA phase I trial of combination chemotherapy employing carboplatin, vinca alkaloids, with or without bleomycin in patients with advanced malignant tumors. _h[electronic resource] |
| 260 |
_bCancer investigation _c1990 |
||
| 300 |
_a135-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aBleomycin _xadministration & dosage |
| 650 | 0 | 4 | _aCarboplatin |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukopenia _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xadministration & dosage |
| 650 | 0 | 4 |
_aVinblastine _xadministration & dosage |
| 650 | 0 | 4 |
_aVindesine _xadministration & dosage |
| 700 | 1 | _aKelsen, D P | |
| 773 | 0 |
_tCancer investigation _gvol. 8 _gno. 2 _gp. 135-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/07357909009017558 _zAvailable from publisher's website |
| 999 |
_c1704511 _d1704511 |
||